⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

NH - Technical Analysis with Chart Patterns & Indicators

Back to List

Rating: 3.7

Last Updated Time : 02 Feb 26, 09:51 am

Technical Rating: 3.7

Stock Code NH Market Cap 36,825 Cr. Current Price 1,802 ₹ High / Low 2,372 ₹
Stock P/E 79.3 Book Value 114 ₹ Dividend Yield 0.25 % ROCE 19.4 %
ROE 21.0 % Face Value 10.0 ₹ DMA 50 1,850 ₹ DMA 200 1,783 ₹
Chg in FII Hold 0.61 % Chg in DII Hold 0.15 % PAT Qtr 138 Cr. PAT Prev Qtr 87.4 Cr.
RSI 45.4 MACD -34.6 Volume 1,83,215 Avg Vol 1Wk 3,11,306
Low price 1,296 ₹ High price 2,372 ₹ PEG Ratio 1.71 Debt to equity 0.69
52w Index 47.0 % Qtr Profit Var 30.6 % EPS 22.7 ₹ Industry PE 45.2

📊 Chart & Trend Analysis:

NH is trading at ₹1,802, below its 50 DMA (₹1,850) but slightly above its 200 DMA (₹1,783), indicating short-term weakness with long-term support intact. RSI at 45.4 suggests neutral momentum, not oversold but lacking strength. MACD at -34.6 shows a strong bearish crossover, signaling downward momentum. Bollinger Bands place price near the lower-mid range, reflecting consolidation with bearish bias. Current volume (1.83 lakh) is lower than the 1-week average (3.11 lakh), showing reduced participation and weak buying interest.

📈 Momentum Signals:

- RSI neutral, leaning bearish.

- MACD strongly negative, confirming short-term weakness.

- Price below 50 DMA but above 200 DMA indicates consolidation with bearish bias.

- Low volume suggests lack of conviction in current moves.

🎯 Optimal Entry & Exit Zones:

- Entry Zone: ₹1,780 – ₹1,800 (near 200 DMA support).

- Exit Zone: ₹1,850 – ₹1,880 (resistance at 50 DMA).

- Stop Loss: ₹1,750 (below key support).

📌 Trend Status: The stock is consolidating with bearish bias, holding above long-term support but failing to sustain above short-term resistance levels.


Positive

  • Strong ROE (21.0%) and ROCE (19.4%) highlight efficient capital use.
  • Quarterly PAT improved to ₹138 Cr. from ₹87.4 Cr., showing earnings growth (+30.6%).
  • EPS of ₹22.7 reflects solid earnings base.
  • FII holding increased (+0.61%), showing foreign investor confidence.
  • DII holding also increased (+0.15%), reflecting domestic institutional support.

Limitation

  • High P/E (79.3) compared to industry average (45.2) suggests overvaluation.
  • Dividend yield of 0.25% is relatively low, limiting income appeal.
  • Debt-to-equity ratio of 0.69 indicates moderate leverage risk.
  • Stock trading below 50 DMA reflects weak short-term technical strength.

Company Negative News

  • MACD strongly negative, signaling bearish momentum.
  • Volume weakness indicates lack of strong investor conviction.

Company Positive News

  • Quarterly profit growth of 30.6% signals operational improvement.
  • FII and DII holdings both increased, reflecting institutional confidence.

Industry

  • Industry P/E at 45.2 is lower than company’s P/E (79.3), suggesting NH is relatively expensive compared to peers.
  • Healthcare sector remains resilient, supported by rising demand and structural growth drivers.

Conclusion

⚖️ NH is consolidating with bearish bias, trading below its 50 DMA but supported by its 200 DMA. While fundamentals remain strong with profit growth, high ROE, and institutional support, valuations are stretched and technical signals show weakness. Short-term traders may consider entry near ₹1,780–₹1,800 with exits around ₹1,850–₹1,880, while long-term investors should wait for valuation correction and stronger momentum before fresh accumulation.

NIFTY 50 - Technical Stock Watchlist

NEXT 50 - Technical Stock Watchlist

MIDCAP - Technical Stock Watchlist

SMALLCAP - Technical Stock Watchlist